Thus, it downregulated STAT3 target genes known to promote HCC development and metastasis, e.g., the cell cycle protein Cyclin D1, the anti-apoptotic protein BCL-2, and the invasion-related metalloproteinase MMP2 [107]. The gene discussed is STAT3; the disease is hepatocellular carcinoma.